Sana Biotechnology Inc (SANA) News

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Sana Biotechnology Announces Proposed Public Offering of Common Stock

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on...

Form 8-K - Current report

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies

SEATTLE, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on...

Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting

Preclinical data with SC262, a HIP-modified CD22-directed allogeneic CAR T cell, further support completed IND...

Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System

SEATTLE, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on...

Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders

Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders PR...

Sana Biotechnology to Present at November and December 2023 Investor Conferences

SEATTLE, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on...

Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics

Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New...